Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Bayer, explained in plain language.
This study will follow 500 men in Germany with metastatic hormone-sensitive prostate cancer (mHSPC) who are taking darolutamide plus standard hormone therapy. The main goal is to see how many men have very low PSA levels after 12 months. Researchers will also track survival and h…
Sponsor: Bayer • Aim: Disease control
Last updated May 15, 2026 11:57 UTC